MARKET

METXF

METXF

ME Therapeutics
OTCPK
--
NaN%
Closed
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
ME Therapeutics Announces It Has Engaged Lucosky Brookman LLP to Explore a Listing on the NASDAQ or NYSE
Newsfile · 03/03 14:00
ME Therapeutics Announces That Its First Therapeutic mRNA Candidate Shows Encouraging Anti-Cancer Efficacy in Vivo
Newsfile · 01/14 14:27
ME Therapeutics Holdings Inc. Appoints Chief Business Officer
Newsfile · 10/25/2024 13:00
ME Therapeutics Holdings Inc. Provides Research and Development Update and Corporate Update
Newsfile · 10/22/2024 10:00
ME Therapeutics Announces the Start of Testing of First mRNA Formulations from NanoVation Therapeutics Collaboration
Newsfile · 09/18/2024 13:00
About METXF
ME Therapeutics Holdings Inc. is a preclinical stage biotechnology company involved in the discovery and development of novel immuno-oncology therapeutics targeting immune suppression in cancer. The Company’s focus is on overcoming the suppressive effects of an important class of immune cells called myeloid cells to enhance anti-cancer immunity. The Company’s lead candidate is a novel high affinity antibody drug that targets a key protein involved in the generation of suppressive myeloid cells. This antibody drug candidate is being developed to treat colorectal cancer. In addition to its antibody drug candidate program, the Company is also developing a novel small molecule prodrug candidate designed to specifically target suppressive myeloid cells in the tumor environment. It has also initiated design and testing of two mRNA-based cancer therapeutic drug candidates. Its lead mRNA candidates target a known mechanism of immune stimulation.

Webull offers ME Therapeutics Holdings Inc stock information, including OTCPK: METXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, METXF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading METXF stock methods without spending real money on the virtual paper trading platform.